Bafna Pharmaceuticals Q3 Results
- BSE: 532989
- NSE: BAFNAPH
- ISIN: INE878I01022
- Sector: Biotechnology & Drugs
BSE
450.95
8.80 (1.99%)
8.80 (1.99%)Volume28.38 K
Updated: Wed 14 Oct, 2026 | 10:06:46
NSE
443.508.65 (1.99%)
8.65 (1.99%)Volume2.31 K
Updated: Wed 14 Oct, 2026 | 09:52:23
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Bafna Pharmaceuticals Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 36.81 | 38.11 | 12.70% | 31.79 | 15.76% |
| Depreciation/ Amortization | 1.57 | 1.58 | 6.61% | 1.27 | -5.18% |
| Operating Income | 1.48 | 2.22 | -47.33% | -3.35 | 6.20% |
| Net Income | 1.84 | 2.62 | -41.22% | -2.94 | 93.83% |
| Other Operating Expenses Total | 2.62 | 3.72 | -0.41% | 2.70 | 110.98% |
| Net Income Before Taxes | 1.84 | 2.62 | -41.22% | -2.94 | 93.83% |
| Total Revenue | 38.29 | 40.32 | 7.94% | 28.44 | 15.36% |
| Selling/ General/ Admin Expenses Total | 5.35 | 5.06 | -2.65% | 4.53 | 1.67% |
| Diluted Normalized EPS | 0.78 | 1.11 | -40.91% | -1.24 | 92.56% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.